About
Our team has created a new pathway for isolating the most valuable stem cells with the longest telomeres, reaching purity levels close to 95% regardless of source. This gives a clear advantage over approaches that rely on naturally younger cell sources and lower-value cell populations.
Our mission is to validate and commercialize this technology now, enabling safer and more affordable regenerative therapies based on a patient’s own selected cells, with strong potential in healthy ageing and other future medical applications.
Folow DEPCELL News on Facebook
May 11, 2026
Facebook post
Pioneering Stem Cell Innovations in Latvia
Discover innovative research and collaborative efforts advancing more accessible stem cell therapy, smarter cell sorting, and medical science in Latvia.
Bridging Research and Stem Cell Innovation
DEPCELL aims to validate a dielectrophoresis-based system for isolating stem cell populations with enhanced therapeutic potential, with the goal of supporting more effective treatment of autoimmune diseases that are not adequately controlled by conventional therapy. The project focuses in particular on psoriasis, Crohn’s disease, type 1 diabetes, and rheumatoid arthritis.
Partners
Contacts
info@depcell.com